Adamas Pharmaceuticals, Inc. Aktie

Aktier

2021-08-09	Adamas Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 09, 2021
2021-05-11	Adamas Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-11-2021 11:45 AM
2021-05-10	Adamas Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 10, 2021
2021-03-02	Adamas Pharmaceuticals, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 02:50 PM
2021-02-23	Adamas Pharmaceuticals, Inc., Q4 2020 Earnings Call, Feb 23, 2021
2021-02-01	Adamas Pharmaceuticals, Inc. - Special Call
2021-01-11	Adamas Pharmaceuticals, Inc. Presents at H.C. Wainwright BioConnect 2021 Conference, Jan-11-2021 06:00 AM
2020-11-05	Adamas Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 05, 2020
2020-08-06	Adamas Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020
2020-05-07	Adamas Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020
2020-02-25	Adamas Pharmaceuticals, Inc., Q4 2019 Earnings Call, Feb 25, 2020
2019-11-07	Adamas Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019
2019-08-08	Adamas Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019

2021-11-24	Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K
2021-11-24	ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
2021-11-24	Adamas Pharmaceuticals, Inc. Announces Management Changes
2021-11-24	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from NASDAQ Composite Index
2021-11-24	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P TMI Index

1 dag

+0,74 %

Verkställande direktör	Titel	Ålder	Sedan
Jack Khattar PSD	President	64	2021-11-24

Styrelseledamot	Titel	Ålder	Sedan
Bryan Roecklein BRD	Direktör/Styrelseledamot	-	2021-11-24
Jack Khattar BRD	Direktör/Styrelseledamot	64	2021-11-24

Datum	Insider	Typ	Huvudposition	Kvantitet	% av börsvärdet.
21-11-24	Michael Bigham	Tender	Styrelseledamot	40 000	0,0875%
21-11-24	Vijay Shreedhar	Kostnadsfri	Chef / ledande befattningshavare	390 536	0,8547%
21-11-24	MDV Management Co. LLC	Tender	Företag	4 619 796	10,1111%

Lägg till i en lista 0 vald För att använda denna funktion måste du vara en kund eller medlem Logga in Registrera dig	Förändring	Utveckling 5 d	Varia. 1 år	Föränd. 3 år	Kapi.($)
ADAMAS PHARMACEUTICALS, INC.	+0,74 %	+0,24 %	-	-	376 mn
WUXI APPTEC CO., LTD.	+0,79 %	−6,16 %	+49,32 %	+74,50 %	66,34 md
LONZA GROUP AG	+1,92 %	+10,35 %	+13,02 %	+87,74 %	52,92 md
ARGENX SE	+6,91 %	+8,57 %	+6,88 %	+72,12 %	54,82 md
IQVIA HOLDINGS INC.	+0,74 %	+2,75 %	+26,31 %	+45,29 %	44,09 md
BEONE MEDICINES AG	+3,87 %	+10,15 %	+20,69 %	+132,73 %	43,72 md
REVOLUTION MEDICINES, INC.	+7,91 %	+4,30 %	+263,91 %	+602,72 %	42,13 md
CELLTRION, INC.	−0,40 %	+9,85 %	+17,04 %	+59,17 %	33,96 md
WUXI BIOLOGICS (CAYMAN) INC.	−1,34 %	−0,72 %	+37,09 %	+7,00 %	26,17 md
GENMAB A/S	+2,36 %	+5,34 %	+30,98 %	+26,07 %	23,37 md
Genomsnitt	+2,35 %	+1,67 %	+51,69 %	+123,04 %	43,06 md
Viktad genomsnitt av Capi.	+2,77 %	+1,99 %	+51,08 %	+127,82 %